Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma

Wenqiao Zang; Tao Wang; Yuanyuan Wang; Xiaonan Chen; Yuwen Du; Qianqian Sun; Min Li; Ziming Dong; Guoqiang Zhao

doi:10.18632/oncotarget.6963

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression of Concern

This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.

Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma

Wenqiao Zang _, Tao Wang, Yuanyuan Wang, Xiaonan Chen, Yuwen Du, Qianqian Sun, Min Li, Ziming Dong and Guoqiang Zhao

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:19960-19974. https://doi.org/10.18632/oncotarget.6963

Metrics: PDF 3044 views | HTML 2883 views | ?

Abstract

Wenqiao Zang1, Tao Wang2, Yuanyuan Wang1, Xiaonan Chen1, Yuwen Du1, Qianqian Sun1, Min Li1, Ziming Dong1,3, Guoqiang Zhao1,3

1College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China

2Department of Hemato-tumor, The First Affiliated Hospital of Henan University of TCM, Zhengzhou, China

3Collaborative Innovation Center of Cancer Chemoprevention, Henan, China

Correspondence to:

Guoqiang Zhao, e-mail: [email protected]

Keywords: LncRNA TP73-AS1, BDH2, biomarker, chemosensitivity, esophageal cancer

Received: July 24, 2015 Accepted: January 13, 2016 Published: January 21, 2016

ABSTRACT

Recent studies have shown that long non-coding RNAs (lncRNAs) are involved in a variety of biological processes and diseases in humans, including cancer. Our study serves as the first comprehensive analysis of lncRNA TP73-AS1 in esophageal cancer. We utilized a lncRNA microarray to analyze the expression profile of lncRNAs in esophageal squamous cell carcinoma. Our results show that lncRNA TP73-AS1 and BDH2 levels are generally upregulated in esophageal cancer tissues and are strongly correlated with tumor location or TNM stage in clinical samples. LncRNA TP73-AS1 knockdown inhibited BDH2 expression in EC9706 and KYSE30 cells, whereas BDH2 knockdown repressed esophageal cancer cell proliferation and induced apoptosis via the caspase-3 dependent apoptotic pathway. Overexpression of BDH2 in lncRNA TP73-AS1 knockdown cells partially rescued cell proliferation rates and suppressed apoptosis. In mouse xenografts, tumor size was reduced in lncRNA TP73-ASI siRNA-transfected tumors, suggesting that downregulation of lncRNA TP73-AS1 attenuated EC proliferation in vitro and in vivo. In addition, BDH2 or lncRNA TP73-AS1 knockdown enhanced the chemosensitivity of esophageal cancer cells to 5-FU and cisplatin. Our results suggest that lncRNA TP73-AS1 may be a novel prognostic biomarker that could serve as a potential therapeutic target for the treatment of esophageal cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6963

Publication Alerts

Post-Publication Promotion

Research Papers:

Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma

Abstract